Journals
Publish with us
Publishing partnerships
About us
Blog
Oxidative Medicine and Cellular Longevity
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Oxidative Medicine and Cellular Longevity
/
2017
/
Article
/
Fig 2
/
Research Article
NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib
Figure 2
Putative NRF2 binding sites in the promoter region of HER1.